23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.
On Sept. 23, the board of directors at 23andMe, a prominent DNA testing company, announced their resignation following a series of disagreements with CEO Ann ...
4don MSN
The history of the DNA-testing startup reads like a checklist of Silicon Valley clichés: founder squabbles, gobs of cash, a ...
Personal information for nearly half of the popular genetic testing company's customers -- 6.9 million people -- were exposed ...
On Monday, 23andMe Holding Co. (ME) stock saw a modest uptick, ending the day at $0.34 which represents no change from the prior close of $0.34. The stock opened at $0.36 and touched a low of $0.34 ...
The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...
Me has agreed to pay $30 million after a class action suit was brought against the company for last year's data breach.
The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...
By letter dated August 2, 2024, a Special Committee of the Board of Directors of 23andMe rejected that offer, noting that it "provide [d] no premium to the closing price per share on Wednesday, July ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback